These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 37109413)

  • 1. Predicting the Efficacy of SBRT for Lung Cancer with
    Chen K; Hou L; Chen M; Li S; Shi Y; Raynor WY; Yang H
    Life (Basel); 2023 Mar; 13(4):. PubMed ID: 37109413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting EGFR mutation subtypes in lung adenocarcinoma using
    Liu Q; Sun D; Li N; Kim J; Feng D; Huang G; Wang L; Song S
    Transl Lung Cancer Res; 2020 Jun; 9(3):549-562. PubMed ID: 32676319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of pre-therapy
    Zhang J; Zhao X; Zhao Y; Zhang J; Zhang Z; Wang J; Wang Y; Dai M; Han J
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1137-1146. PubMed ID: 31728587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiblock Discriminant Analysis of Integrative
    Lee SH; Kao GD; Feigenberg SJ; Dorsey JF; Frick MA; Jean-Baptiste S; Uche CZ; Cengel KA; Levin WP; Berman AT; Aggarwal C; Fan Y; Xiao Y
    Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1451-1465. PubMed ID: 33662459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A PET/CT radiomics model for predicting distant metastasis in early-stage non-small cell lung cancer patients treated with stereotactic body radiotherapy: a multicentric study.
    Yu L; Zhang Z; Yi H; Wang J; Li J; Wang X; Bai H; Ge H; Zheng X; Ni J; Qi H; Guan Y; Xu W; Zhu Z; Xing L; Dekker A; Wee L; Traverso A; Ye Z; Yuan Z
    Radiat Oncol; 2024 Jan; 19(1):10. PubMed ID: 38254106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of 18F-FDG PET/CT imaging radiomics in the differential diagnosis of single-nodule pulmonary metastases and second primary lung cancer in patients with colorectal cancer.
    Yu Y; Zhu J; Sang S; Yang Y; Zhang B; Deng S
    J Cancer Res Ther; 2024 Apr; 20(2):599-607. PubMed ID: 38687930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting PD-L1 expression status in patients with non-small cell lung cancer using [
    Zhao X; Zhao Y; Zhang J; Zhang Z; Liu L; Zhao X
    EJNMMI Res; 2023 Jan; 13(1):4. PubMed ID: 36682020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of
    Zhang M; Bao Y; Rui W; Shangguan C; Liu J; Xu J; Lin X; Zhang M; Huang X; Zhou Y; Qu Q; Meng H; Qian D; Li B
    Front Oncol; 2020; 10():568857. PubMed ID: 33134170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of EGFR mutation status in lung adenocarcinoma based on
    Tan JL; Xia L; Sun SG; Zeng H; Lu DY; Cheng XJ
    Am J Nucl Med Mol Imaging; 2023; 13(5):230-244. PubMed ID: 38023818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET/CT Radiomic Features: A Potential Biomarker for EGFR Mutation Status and Survival Outcome Prediction in NSCLC Patients Treated With TKIs.
    Yang L; Xu P; Li M; Wang M; Peng M; Zhang Y; Wu T; Chu W; Wang K; Meng H; Zhang L
    Front Oncol; 2022; 12():894323. PubMed ID: 35800046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting MYCN amplification in paediatric neuroblastoma: development and validation of a 18F-FDG PET/CT-based radiomics signature.
    Qian LD; Zhang SX; Li SQ; Feng LJ; Zhou ZA; Liu J; Zhang MY; Yang JG
    Insights Imaging; 2023 Nov; 14(1):205. PubMed ID: 38001240
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Xue XQ; Yu WJ; Shi X; Shao XL; Wang YT
    Front Oncol; 2022; 12():911168. PubMed ID: 36003788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiogenomic Models Using Machine Learning Techniques to Predict EGFR Mutations in Non-Small Cell Lung Cancer.
    Nair JKR; Saeed UA; McDougall CC; Sabri A; Kovacina B; Raidu BVS; Khokhar RA; Probst S; Hirsh V; Chankowsky J; Van Kempen LC; Taylor J
    Can Assoc Radiol J; 2021 Feb; 72(1):109-119. PubMed ID: 32063026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of
    Shao X; Niu R; Shao X; Jiang Z; Wang Y
    EJNMMI Res; 2020 Jul; 10(1):80. PubMed ID: 32661639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of
    Li S; Li Y; Zhao M; Wang P; Xin J
    Korean J Radiol; 2022 Sep; 23(9):921-930. PubMed ID: 36047542
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Qian LD; Zhou ZA; Li SQ; Liu J; Zhang SX; Ren JL; Wang W; Yang J
    Quant Imaging Med Surg; 2024 Apr; 14(4):3131-3145. PubMed ID: 38617169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and Validation of a Radiomics Nomogram Based on
    Yang B; Zhong J; Zhong J; Ma L; Li A; Ji H; Zhou C; Duan S; Wang Q; Zhu C; Tian J; Zhang L; Wang F; Zhu H; Lu G
    Front Oncol; 2020; 10():1042. PubMed ID: 32766134
    [No Abstract]   [Full Text] [Related]  

  • 18. Pretreatment
    Dissaux G; Visvikis D; Da-Ano R; Pradier O; Chajon E; Barillot I; Duvergé L; Masson I; Abgral R; Santiago Ribeiro MJ; Devillers A; Pallardy A; Fleury V; Mahé MA; De Crevoisier R; Hatt M; Schick U
    J Nucl Med; 2020 Jun; 61(6):814-820. PubMed ID: 31732678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body Composition and Radiomics From 18 F-FDG PET/CT Together Help Predict Prognosis for Patients With Stage IV Non-Small Cell Lung Cancer.
    Zhang Y; Tan W; Zheng Z; Wang J; Xing L; Sun X
    J Comput Assist Tomogr; 2023 Nov-Dec 01; 47(6):906-912. PubMed ID: 37948365
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Qian LD; Feng LJ; Zhang SX; Liu J; Ren JL; Liu L; Zhang H; Yang J
    Quant Imaging Med Surg; 2023 Jan; 13(1):94-107. PubMed ID: 36620179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.